Alnylam Pharmaceuticals Net Non-Operating Interest Income Expense (Quarterly) Insights

Alnylam Pharmaceuticals, Inc. (ALNY)

328.54 -4.31 (-1.29%) USD | NASDAQ | Feb 25, 14:50

View Net Non-Operating Interest Income Expense (Quarterly) for ALNY.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Net Non-Operating Interest Income Expense (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Net Non-Operating Interest Income Expense (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Net Non-Operating Interest Income Expense (Quarterly) Benchmarks

Start Trial